T1	Participants 73 145	patients with severe chronic congestive heart failure: the PROMISE Study
T2	Participants 263 320	patients with moderate to severe congestive heart failure
T3	Participants 591 667	1,068 patients enrolled in a survival study of class III or IV heart failure
